These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34075667)

  • 1. Topical beta-blockers in dermatologic therapy.
    Filoni A; Ambrogio F; De Marco A; Pacifico A; Bonamonte D
    Dermatol Ther; 2021 Jul; 34(4):e15016. PubMed ID: 34075667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-Blockers for Pyogenic Granuloma: A Systematic Review of Case Reports, Case Series, and Clinical Trials.
    Dany M
    J Drugs Dermatol; 2019 Oct; 18(10):1006-1010. PubMed ID: 31584779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are topical beta-blockers really effective "in real life" for targeted therapy-induced paronychia.
    Sibaud V; Casassa E; D'Andrea M
    Support Care Cancer; 2019 Jul; 27(7):2341-2343. PubMed ID: 30847700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical timolol in dermatology: infantile haemangiomas and beyond.
    Alzaid M; Al-Naseem A; Al-Niaimi F; Ali FR
    Clin Exp Dermatol; 2022 May; 47(5):819-832. PubMed ID: 34798680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of topical beta-blockers in the management of EGFR-inhibitor induced paronychia and pyogenic granuloma-like lesions: case series and review of the literature.
    Sollena P; Mannino M; Tassone F; Calegari MA; D'Argento E; Peris K
    Drugs Context; 2019; 8():212613. PubMed ID: 31798664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of pediatric pyogenic granulomas using β-adrenergic receptor antagonists.
    Wine Lee L; Goff KL; Lam JM; Low DW; Yan AC; Castelo-Soccio L
    Pediatr Dermatol; 2014; 31(2):203-7. PubMed ID: 24138457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical timolol: An effective treatment option for agminated pyogenic granuloma.
    McGinness A; Gillam A; Yeh I; Mathes EF
    Pediatr Dermatol; 2018 Sep; 35(5):e300-e303. PubMed ID: 29961974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is timolol an effective treatment for pyogenic granuloma?
    Gupta D; Singh N; Thappa DM
    Int J Dermatol; 2016 May; 55(5):592-5. PubMed ID: 26872444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical β-blockers for pyogenic granulomas: A promising option for younger patients.
    El-Taweel AEI; Al-Refaie AAA; Salem KHA; Salem RM
    J Cosmet Dermatol; 2021 Jun; 20(6):1801-1806. PubMed ID: 33128492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RF - FTopical Timolol in Dermatology.
    Lopez-Bernal T; Aranegui B
    Actas Dermosifiliogr; 2023 Apr; 114(4):334-335. PubMed ID: 36126701
    [No Abstract]   [Full Text] [Related]  

  • 11. Timolol for the treatment of pyogenic granuloma (PG) in children.
    Knöpfel N; Escudero-Góngora MDM; Bauzà A; Martín-Santiago A
    J Am Acad Dermatol; 2016 Sep; 75(3):e105-e106. PubMed ID: 27543231
    [No Abstract]   [Full Text] [Related]  

  • 12. A pyogenic granuloma treated with topical timolol.
    Malik M; Murphy R
    Br J Dermatol; 2014 Dec; 171(6):1537-8. PubMed ID: 24836966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repurposing Ophthalmologic Timolol for Dermatologic Use: Caveats and Historical Review of Adverse Events.
    Yoon DJ; Kaur R; Gallegos A; West K; Yang H; Schaefer S; Tchanque-Fossuo C; Dahle SE; Isseroff RR
    Am J Clin Dermatol; 2021 Jan; 22(1):89-99. PubMed ID: 33237496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical timolol for an iris hemangioma.
    Gummi R; Stahl ED; Marsh JD
    J AAPOS; 2018 Apr; 22(2):156-158. PubMed ID: 29412149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical timolol as adjunct therapy to shorten oral propranolol therapy for infantile hemangiomas.
    Mannschreck DB; Huang AH; Lie E; Psoter K; Puttgen K
    Pediatr Dermatol; 2019 May; 36(3):283-289. PubMed ID: 30968438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical Timolol Maleate Treatment of Infantile Hemangiomas.
    Püttgen K; Lucky A; Adams D; Pope E; McCuaig C; Powell J; Feigenbaum D; Savva Y; Baselga E; Holland K; Drolet B; Siegel D; Morel KD; Garzon MC; Mathes E; Lauren C; Nopper A; Horii K; Newell B; Song W; Frieden I;
    Pediatrics; 2016 Sep; 138(3):. PubMed ID: 27527799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local administration of β-blockers for infantile hemangiomas: a systematic review and meta-analysis.
    Ovadia SA; Landy DC; Cohen ER; Yang EY; Thaller SR
    Ann Plast Surg; 2015 Feb; 74(2):256-62. PubMed ID: 25590249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical Timolol for Infantile Hemangiomas: Evidence for Efficacy and Degree of Systemic Absorption.
    Weibel L; Barysch MJ; Scheer HS; Königs I; Neuhaus K; Schiestl C; Rentsch K; Müller DM; Theiler M
    Pediatr Dermatol; 2016; 33(2):184-90. PubMed ID: 26840644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of topical beta blockers as treatment for infantile hemangiomas.
    Painter SL; Hildebrand GD
    Surv Ophthalmol; 2016; 61(1):51-8. PubMed ID: 26408055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of topical timolol in wound healing and the treatment of vascular lesions: A narrative review.
    Goodarzi A; Mozafarpoor S; Dodangeh M; Seirafianpour F; Shahverdi MH
    Dermatol Ther; 2021 Mar; 34(2):e14847. PubMed ID: 33538017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.